Update in Cardiology
Authors: Elliot Rapaport
Journal: Annals of Internal Medicine (2006)

Updates17 October 2006Update in CardiologyElliot Rapaport, MDElliot Rapaport, MDFrom San Francisco General Hospital and University of California, San Francisco, San Francisco, California.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-145-8-200610170-00011 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail This Update in Cardiology features 13 articles published in 2005. They were chosen from among thousands because of their particular interest or importance to the field, focusing on hypertension, diabetes and cardiovascular disease, acute myocardial infarction, and heart failure. Changes to clinical practice emerging from these articles are shown in the Table .Table. Changes to Clinical Practice Emerging from Articles Important to Cardiologists in 2005*HypertensionAmlodipine Prevented More Major Cardiovascular Events and Induced Less Diabetes than Atenolol ...References1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72. [PMID: 12748199] CrossrefMedlineGoogle Scholar2. Yusuf S, Mehta SR, Xie C, Ahmed RJ, Xavier D, Pais P, et al. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. JAMA. 2005;293:427-35. [PMID: 15671427] CrossrefMedlineGoogle Scholar3. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:671-719. [PMID: 15358045] MedlineGoogle Scholar4. Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006;354:1477-88. [PMID: 16537665] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From San Francisco General Hospital and University of California, San Francisco, San Francisco, California.Disclosures:Consultancies: Sanofi, Bristol-Myers Squibb, Pfizer Inc.; Honoraria: Sanofi, Bristol-Myers Squibb, AstraZeneca. Dr. Rapaport has also provided expert testimony in malpractice cases for some law firms in Utah.Corresponding Author: Elliot Rapaport, MD, Cardiology Division, Room 5G1, San Francisco General Hospital, 1001 Potrero Street, San Francisco, CA 94110. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoFirst-Line Therapy for Hypertension Mohsen S. Eledrisi Metrics Cited ByFirst-Line Therapy for HypertensionMohsen S. Eledrisi, MD 17 October 2006Volume 145, Issue 8Page: 618-625KeywordsACE inhibitorsHeart failureHemorrhageHypertensionStroke ePublished: 17 October 2006 Issue Published: 17 October 2006 CopyrightCopyright © 2006 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...